- Home
- OUST vs CERT Comparison
OUST vs CERT Comparison
Compare OUST & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OUST | CERT |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 860.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | OUST | CERT |
|---|---|---|
| Price | $32.63 | $4.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $39.25 | $11.67 |
| AVG Volume (30 Days) | ★ 4.3M | 3.1M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $33.20 | $4.18 |
| Revenue Next Year | $37.27 | $5.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $10.06 | $4.45 |
| 52 Week High | $41.65 | $13.88 |
Technical Indicators
Market Signals| Indicator | OUST | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 60.98 | 33.16 |
| Support Level | $26.35 | N/A |
| Resistance Level | $36.03 | $6.47 |
| Average True Range (ATR) | 3.77 | 0.32 |
| MACD | 0.11 | -0.10 |
| Stochastic Oscillator | 73.78 | 16.96 |
Price Performance
Historical ComparisonAbout OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.